The disclosure relates to a method for the differentiation of stem cells to endothelial cells, vascular smooth muscle cells, fibroblasts and keratinocytes； their use in the production of a organotypic vascularized skin or mucosa model or composition； a method relating thereto； the use of the model or composition in the testing of pharmaceutical and/or cosmetic agents； and including therapeutic and cosmetic skin compositions developed or tested thereby.
